Agent prevents prostate cancer growth, spread in animal studies

Researchers have completed a critical step in the journey from a basic science discovery in the lab to a potential clinical application by showing an experimental agent prevents tumor growth and spread in mice with prostate cancer harboring a common chromosomal abnormality. The agent, YK-4-279, is the first drug targeted at the chromosomal translocations found in about half of prostate cancer cells.

Read the whole article on Science Daily

More from Science Daily